Oaktree Acquisition Corp III Life Sciences
OACC
47 hedge funds and large institutions have $172M invested in Oaktree Acquisition Corp III Life Sciences in 2025 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 3 closing their positions.
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
21% more funds holding
Funds holding: 39 → 47 (+8)
13% more capital invested
Capital invested by funds: $153M → $172M (+$19.3M)
7.5% more ownership
Funds ownership: 75.81% → 83.31% (+7.5%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HighTower Advisors
Chicago,
Illinois
|
+$5.7M |
| 2 |
MCM
Moore Capital Management
New York
|
+$5.45M |
| 3 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$5.19M |
| 4 |
LIP
Lighthouse Investment Partners
Palm Beach Gardens,
Florida
|
+$4.15M |
| 5 |
GL
Governors Lane
New York
|
+$3.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCI
Harraden Circle Investments
New York
|
-$5.14M |
| 2 |
ECM
ExodusPoint Capital Management
New York
|
-$3M |
| 3 |
DAM
DLD Asset Management
New York
|
-$2.59M |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$2.59M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$2.59M |
OACC Hedge Fund Activity: Q2 2025 in Review
47 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences (OACC) for Q2 2025, worth a combined $172M — up 13% from $153M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new OACC positions and 3 closed out — a net gain of 8 holders — while 8 added to existing stakes and 11 trimmed.
The largest buyer was HighTower Advisors, adding an estimated $5.7M. The largest seller was Harraden Circle Investments, exiting entirely with an estimated $5.14M sold.
- 47 institutional investors held Oaktree Acquisition Corp III Life Sciences (OACC) as of Q2 2025, up from 39 in Q1 2025.
- Funds reported $172M of Oaktree Acquisition Corp III Life Sciences stock for Q2 2025, up 13% quarter-over-quarter.
- 11 funds opened new Oaktree Acquisition Corp III Life Sciences positions in Q2 2025 and 3 closed out, a net change of +8 holders.
- The largest Oaktree Acquisition Corp III Life Sciences buyer in Q2 2025 was HighTower Advisors, an estimated $5.7M added.
- The largest Oaktree Acquisition Corp III Life Sciences seller in Q2 2025 was Harraden Circle Investments, an estimated $5.14M sold.
Based on aggregated 13F filings for Q2 2025.